Comprehensive predictive biomarker evaluation in two phase II clinical trials of the PI3K/mTOR inhibitor GDC-0980 in metastatic renal cell carcinoma and advanced endometrial cancer Meeting Abstract
| Authors: | Spoerke, J. M.; Makker, V.; Aghajanian, C.; Thomas, P.; Motzer, R. J.; Lauchle, J. O.; Parmar, H.; Gilbert, H.; Lin, W.; O'Keeffe, B.; Byrtek, M.; Koeppen, H.; Wang, Y. L.; Lu, S.; Huw, L. Y.; Hampton, G. M.; Lackner, M. R. |
| Abstract Title: | Comprehensive predictive biomarker evaluation in two phase II clinical trials of the PI3K/mTOR inhibitor GDC-0980 in metastatic renal cell carcinoma and advanced endometrial cancer |
| Meeting Title: | AACR Special Conference: Targeting the PI3K-mTOR Network in Cancer |
| Journal Title: | Molecular Cancer Therapeutics |
| Volume: | 14 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2014 Sep 14-17 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 1535-7163 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-07-01 |
| Language: | English |
| ACCESSION: | WOS:000358159200004 |
| DOI: | 10.1158/1538-8514.pi3k14-a03 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract A03 -- S -- Source: Wos |
